Anglonordic life science conference 2023 - Invest in Denmark
Anglonordic life science conference 2023 - Invest in Denmark

Conference

Meet us at the AngloNordic life science conference 2023

Conference

Meet us at the AngloNordic life science conference 2023

Looking for new investment or partnership opportunities? Denmark is ranked among the best countries in Europe for development of biotechnology, medtech and digital health. We are ready to help your company look at investment, business or research opportunities in Denmark. 

  • When

    19. May 2023 08:00 to 20. May 2023 17:00

Info

Conference information

When?

20 April: Conference at County Hall, London

Where?

London.

Programme?

Find the complete programme on the conference's website.

Sign up?

The Anglonordic Life Science Conference has a “by-invitation-only” policy. To request an invitation please reach out to Invest in Denmark’s dedicated advisor (Berit Chavez Azeri [email protected]) or directly to the organisers.

More information can be found here.

Get to know Denmark's

world-leading life science hub 

Whether your company is looking for R&D collaborations, licensing, direct investment or expansion opportunities, Denmark has much to offer as with significant strongholds in biotech, medtech and digital health. 

Denmark is one of the most R&D intensive countries in the world and the best in Europe in terms of researcher concentration. Overall, Denmark has the 3rd largest commercial drug development pipeline in Europe. On a per capita basis, we have the world’s highest percentage of patents in biotechnology and the highest number of biotech companies. Denmark is also the country that conducts the most clinical trials per capita. 

With access to specialised talent and a highly productive and innovative biotech industry, Denmark is a very attractive location to invest in and place your research activities. 

Join us at Anglonordic

How can we help you?

Come and chat with us at Anglonordic Life Science Conference 2023 to discuss how Invest in Denmark can help you. We assist foreign companies who are considering to invest or establish business or research activities in Denmark, all free of charge and in full confidentiality. 

Our services to investors, biotech, medtech or digital health companies include:

  • Facilitating contact with potential partners, public authorities and research institutions.
  • Targeted introductions and sourcing for investors including drug pipeline overview and introductions to other investors for potential syndicated investments
  • Tailored solutions for locating your project, business or research activities in Denmark
  • Information and analysis relevant to establishing business activities in Denmark
  • For more information please contact Berit Chavez Azeri on [email protected]

Our services to Danish biotech, medtech or digital health companies

  • Attend AngloNordic Life Science conference as part of a broader programme helping you scale to the UK or find strategic investors
  • For more information please contact Ilana Krasnik from the Trade Council on [email protected]

Choose Denmark because...

What is Anglonordic life science conference?

  • Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
  • The one-day conference provides exceptional value through panel discussions, parallel technology and biotech investment rooms and one-to-one meetings.

Take a deep dive into

the Danish world-leading biotech industry here

As an international hub for life sciences, Denmark offers foreign companies a respected international health laboratory. A politically favourable climate to the life science industry, a world-class research environment, and a strong, ambitious, and innovative life science cluster with a highly skilled labour pool, all supports the establishment of your life science business in Denmark. 

Would you like to meet us?

Please use the event matchmaking tool to book a meeting or reach out directly to our dedicated advisor: